MicroceLac 100
€0.00
Description
Lactose and microcrystalline cellulose are very well established excipients. Both are naturally derived and used frequently as diluents/binder in oral dosage formulations (ODT).
In a effort to obtain synergistic effects, such as improved tablet hardness and adherence capacity, by combining both excipients, spray-dyring was used in order to bring Lactose and Microcrystalline cellulose together. As a result MicroceLac® 100, a co-processed excipient, was achieved, that provides capability for direct compression, due to given flowability and compactability.
MicroceLac® 100 comprises 75 % alpha-lactose monohydrate and 25 % microcrystalline cellulose (MCC), both maintaining their individual chemical identities.
Shelf life / Retest:
18 months
Typical Values
- Bulk Density [g/l]: 460
- Tapped Density [g/l] : 580
- Hausner factor: 1.26
- Carrs index: 20.69 %
Standard Packaging:
20 kg – Paper bag with PE-EVOH-PE Inliner
Particle size distribution [Air jet sieve]
- <32 µm: NMT 15%
- <160 µm: 45-70%
- <250 µm: NLT 90%
Benefits
- Good content uniformity due to low segregation tendency of the active ingredient
- Smooth surface of the resulting cores for easy and economical coating
- Compaction of delicate active ingredients due to excellent compactability
- Consistent tablet hardness due to constant lactose/cellulose ratio
- High weight consistency at various tabletting speed.
Areas of Application
- MicroceLac® 100 is primarily designed for direct compression.
- In comparison with its corresponding physical blend MicroceLac® 100 provides improved tablet hardness, superior flowability and higher adherence capacity, that prevents segregation of a blended API and excipient.
- Due to its adherence capacity MicroceLac® 100 can be used in low dosage formulation. MicroceLac® 100’s superior hardness yield enables its use in high dosage formulations as well.
Particle size distribution batch-to-batch consistency of MicroceLac® 100 by air-jet-sieving.Data obtained from a permanent in-process-controll (IPC) of subsequent batches over a time period of 12 months.
Particle size distribution batch-to-batch consistency of MicroceLac® 100 by air-jet-sieving.Data obtained from a permanent in-process-controll (IPC) of subsequent batches over a time period of 12 months.
Additional information
| Manufacturer | Meggle |
|---|---|
| Quality | Compound of Lactose Monohydrate USP/NF, EP, JP, JP and Microcrystalline Cellulose USP/NF |
| Composition | Compound of Lactose & MCC |
| Dosage Form | Capsules, Tablets |
| Function | Direct compression, dry granulation and capsule filling. Suitable for use in low as well as high dose formulations. Also, used as cores for coating |
You may also like…
-
RetaLac
€0.00 Select options This product has multiple variants. The options may be chosen on the product page
